January 2025

BP drug recalled | Tracking the cardiologist shortage | 'We will miss him greatly' | $36M for new IVL tech ()
FDA clears new-look blood test for Lp(a) | Lawsuit against doc dismissed | Updated data on PVL after TAVR | Startup raises $2M ()
New data on SAVR vs. TAVR | A key tricuspid valve update | Philips sells part of portfolio to PE firm ()
Yes, cannabis use is bad for the heart | Young SAVR patients live longer with mechanical valves | STS elects a new president ()
AI for heart failure risk | TAVR valve leaflet spontaneously ruptures | Extreme diet leaves cholesterol on patient's hands ()
Week in Review: Drug price negotiations | Trends in interventional cardiology | Doc sues health system | Valve durability & TAVR ()
Interest in LBBAP on the rise | Heart monitor software recalled for not sending alerts | COVID-induced arrhythmias ()
Key trends in interventional cardiology | Valve durability after TAVR | Late-breakers announced for ACC.25 ()
Surgeons make history again | Early outcomes with the Myval TAVR valve | Cardiologist sues health system over discrimination ()
Previewing the trends & tech of STS 2025 | Treating COVID-induced arrhythmias | IVL from a medical billing perspective ()
Semaglutide chosen for drug price negotiations | When stress helps surgeons | Calcium scores predict TAVR complication ()
FDA regulator takes on AI, cardiology & more | Diabetes reduces survival after SAVR, but not TAVR | Medtronic at AF Symposium ()
Week in Review: Major recalls hit cardiology | AI approvals continue | Robotic mitral repair | Rising interest in LBBAP ()
Key details about the Evoque TTVR device | Rising interest in LBBAP | AI detects 'fingerprints' in the eye that predict strokes ()
More surgical devices recalled over ongoing safety concerns | Worrisome disparities in care for PAD patients ()
Momentum continues for renal denervation | The 'new era' of HFpEF treatment | A world record for heart transplants ()
Heart monitor software recalled over failure to send alerts | Why EP needs a champion | Medtronic expands carotid portfolio ()
Cardiology still a leader in AI approvals | Robotic mitral repair vs. conventional surgery | J&J gains key approval ()
Week in Review: J&J puts research on hold | The best diets for heart health | Boston Scientific enters IVL arms race ()
A hospital's guide to higher CCTA payments | Compensation rising for cardiology APPs | Loving tributes to UW cardiologist ()
Boston Scientific enters IVL arms race | J&J pauses use of PFA system in US | Surgery outperforms PCI ()
Heart device impresses FDA | Stryker acquires Inari Medical for $4.9B | CES 2025 | Limiting TAVR complications ()
Popular drug benefits heart bypass patients | Why a Boston Scientific TAVR valve fell short | TPVR device gains CE mark approval ()
The best diets for heart health | Young child treated with heart device for very first time | ‘A victory for TAVR’ ()
Screening via CCTA and AI goes to trial | Practical approaches to post-stroke AF monitoring | Top video content from 2024 ()